Lipocine Inc. Quarterly Return On Equity in % from Q2 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lipocine Inc. quarterly/annual Return On Equity history and growth rate from Q2 2013 to Q3 2024.
  • Lipocine Inc. Return On Equity for the quarter ending September 30, 2024 was -19.2 %, a 65.1% increase year-over-year.
  • Lipocine Inc. annual Return On Equity for 2023 was -63.3 %, a 129% decline from 2022.
  • Lipocine Inc. annual Return On Equity for 2022 was -27.7 %, a 1606% decline from 2021.
  • Lipocine Inc. annual Return On Equity for 2021 was -1.62 %, a 99% increase from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -19.2 +35.8 +65.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -38.6 -2.53 -7.02% Apr 1, 2024 Jun 30, 2024
Q1 2024 -37.6 -6.91 -22.5% Jan 1, 2024 Mar 31, 2024
Q4 2023 -63.3 -35.6 -129% Oct 1, 2023 Dec 31, 2023
Q3 2023 -55 -64.9 -655% Jul 1, 2023 Sep 30, 2023
Q2 2023 -36.1 -44.6 -523% Apr 1, 2023 Jun 30, 2023
Q1 2023 -30.7 -28.8 -1494% Jan 1, 2023 Mar 31, 2023
Q4 2022 -27.7 -26 -1606% Oct 1, 2022 Dec 31, 2022
Q3 2022 9.9 +66.2 Jul 1, 2022 Sep 30, 2022
Q2 2022 8.52 +78.9 Apr 1, 2022 Jun 30, 2022
Q1 2022 -1.93 +85.1 +97.8% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.62 +168 +99% Oct 1, 2021 Dec 31, 2021
Q3 2021 -56.3 +139 +71.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -70.4 +151 +68.2% Apr 1, 2021 Jun 30, 2021
Q1 2021 -87 +119 +57.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -169 -25.7 -17.9% Oct 1, 2020 Dec 31, 2020
Q3 2020 -195 -63.8 -48.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 -221 -108 -95.4% Apr 1, 2020 Jun 30, 2020
Q1 2020 -206 -104 -102% Jan 1, 2020 Mar 31, 2020
Q4 2019 -144 -53.6 -59.5% Oct 1, 2019 Dec 31, 2019
Q3 2019 -132 -41.7 -46.5% Jul 1, 2019 Sep 30, 2019
Q2 2019 -113 -25.9 -29.6% Apr 1, 2019 Jun 30, 2019
Q1 2019 -102 -13.1 -14.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -90.1 +0.34 +0.38% Oct 1, 2018 Dec 31, 2018
Q3 2018 -89.8 -15.2 -20.4% Jul 1, 2018 Sep 30, 2018
Q2 2018 -87.4 -21.4 -32.4% Apr 1, 2018 Jun 30, 2018
Q1 2018 -89.1 -27.7 -45.2% Jan 1, 2018 Mar 31, 2018
Q4 2017 -90.5 -27.5 -43.7% Oct 1, 2017 Dec 31, 2017
Q3 2017 -74.6 -14.1 -23.4% Jul 1, 2017 Sep 30, 2017
Q2 2017 -66 -4.51 -7.34% Apr 1, 2017 Jun 30, 2017
Q1 2017 -61.4 -10.8 -21.4% Jan 1, 2017 Mar 31, 2017
Q4 2016 -63 -18.6 -41.8% Oct 1, 2016 Dec 31, 2016
Q3 2016 -60.5 -13 -27.4% Jul 1, 2016 Sep 30, 2016
Q2 2016 -61.4 -15 -32.4% Apr 1, 2016 Jun 30, 2016
Q1 2016 -50.6 +12.9 +20.3% Jan 1, 2016 Mar 31, 2016
Q4 2015 -44.4 +17.9 +28.8% Oct 1, 2015 Dec 31, 2015
Q3 2015 -47.5 +8.1 +14.6% Jul 1, 2015 Sep 30, 2015
Q2 2015 -46.4 +5.54 +10.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 -63.5 -15.5 -32.3% Jan 1, 2015 Mar 31, 2015
Q4 2014 -62.3 -9.6 -18.2% Oct 1, 2014 Dec 31, 2014
Q3 2014 -55.6 -44 -382% Jul 1, 2014 Sep 30, 2014
Q2 2014 -52 -149 -153% Apr 1, 2014 Jun 30, 2014
Q1 2014 -48 Jan 1, 2014 Mar 31, 2014
Q4 2013 -52.7 Oct 1, 2013 Dec 31, 2013
Q3 2013 -11.5 Jul 1, 2013 Sep 30, 2013
Q2 2013 97.4 Apr 1, 2013 Jun 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.